查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
免疫分析市场 - 策略和趋势：依应用、技术、产品、使用者和国家/地区进行预测 - 附加执行顾问指南（2024-2028）
市场调查报告书
商品编码
1472614

免疫分析市场 - 策略和趋势：依应用、技术、产品、使用者和国家/地区进行预测 - 附加执行顾问指南（2024-2028）

IMMUNOASSAY MARKETS. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 409 Pages | 商品交期: 最快1-2个工作天内

价格

诊断产业的旗舰产品再次成为关注的焦点。这场大流行对快速、便捷的诊断产生了新的需求。免疫测定在其中发挥了作用。遗传知识的进步正在为免疫分析创造新的市场。多厅影院正成为筹码。虽然快速诊断、现场护理、生物标记和消费者市场正在扩大，但传统的免疫测定方法在不断增长的临床诊断市场中保持着强势地位。

该报告考察了全球免疫分析市场，并提供了市场概述，包括依应用、技术、产品、用户、国家和参与市场的公司概况划分的趋势。

目录

第一章 市场引导

第二章介绍和市场定义

  • 免疫分析市场定义
  • 市场定义
  • 调查方法
  • 观点：医疗保健和IVD产业

第三章 行业概况

  • 市场进入组织
    • 学术研究所
    • 诊断测试开发人员
    • 仪器仪表供应商
    • 药品及试剂製造商
    • 病理学供应商
    • 独立临床实验室
    • 公共国家/地区实验室
    • 医院实验室
    • 临床实验室
    • 审计机构
    • 认证机构
  • 临床检测细分市场
  • 免疫分析 - 市场和讨论

第四章 市场趋势

  • 增长动力
  • 生长抑制因素
  • 免疫分析设备

第五章免疫分析方法的最新进展

第六章 主要公司简介

  • Abbott Laboratories
  • Abcam
  • Abionic
  • Accel Diagnostics
  • Agilent
  • Akonni Biosystems
  • Applied BioCode
  • Arlington Scientific
  • Arrayit Corporation
  • Atomo Diagnostics
  • Aureum Diagnostics
  • Aurora Biomed
  • Autobio Diagnostics
  • AVIVA Systems Biology
  • Awareness Technology
  • Axis-Shield Diagnostics Ltd.
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • Biocartis
  • Biomatik
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Synthesis
  • Bio-Techne
  • Boditech Med, Inc
  • Boster Biological Technology
  • Bruker
  • Cerstest Biotec
  • Chembio
  • CTK Biotech
  • Cue Health
  • Cytena
  • Diasorin S.p.A.
  • Dynex Technologies
  • Eiken Chemical
  • Enzo Biochem
  • Eurofins Scientific
  • Fluxion Biosciences（Cell Microsystems）
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Global Access Diagnostics
  • Gold Standard Diagnostics
  • Greiner Bio-One
  • Grifols
  • Hycor Biomedical
  • Immunodiagnostic Systems（IDS）
  • Iollo
  • JR Biomedical
  • LightDeck Diagnostics
  • LumiraDx
  • Maxim Biomedical
  • Meso Scale Discovery
  • Millipore Sigma
  • Mindray
  • Molecular Devices
  • MP Biomedical
  • Operon
  • OraSure Technologies
  • Qiagen
  • QuidelOrtho
  • R&D Systems
  • Randox Toxicology
  • R-Biopharm AG
  • Response Biomedical
  • Revvity
  • Roche Diagnostics
  • SD Biosensor
  • Siemens Healthineers
  • Standard BioTools
  • Sysmex
  • Tecan
  • Thermo Fisher Scientific
  • TOSOH Bioscience
  • Uniogen
  • Veramarx
  • Veredus Laboratories
  • Vircell
  • Wantai Biopharm
  • Werfen
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第七章 世界市场

  • 依国家划分的世界市场
  • 依应用划分的全球市场
  • 依技术划分的世界市场
  • 依产品划分的全球市场
  • 依用户划分的全球市场

第八章全球免疫分析市场（依应用）

  • 内分泌学
  • 免疫
  • 肿瘤学
  • 感染
  • 心臟病学
  • 其他

第九章全球免疫分析市场（依技术）

  • 酵素
  • 萤光
  • 化学发光
  • 核酸
  • 快速/POC
  • 其他

第十章全球免疫分析市场，依产品

  • 机器
  • 试剂
  • 服务

第十一章全球免疫分析市场，依使用者划分

  • 医院
  • 门诊检查室
  • 概念验证/其他

第十二章免疫分析的未来愿景

第十三章附录

OVERVIEW:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Immunoassay Market-Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. Immunoassay Markets Definition In This Report
    • 2.1.1. Enzyme Based
    • 2.1.2. Immunofluorescence
    • 2.1.3. Chemiluminescence
    • 2.1.4. DNA/NAT
    • 2.1.5. RIA & Other
    • 2.1.6. Reagents/Kits, Analyzers, Software & Services
    • 2.1.7. Infectious Disease
    • 2.1.8. Auto Immune
    • 2.1.9. Endocrinology
    • 2.1.10. Oncology
    • 2.1.11. Cardiology
    • 2.1.12. Other Specialty
  • 2.2. Market Definition
    • 2.2.1. Market Sizes
    • 2.2.2. Currency
    • 2.2.3. Years
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. The Clinical Laboratory Market Segments
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
    • 3.2.3. Hospital Testing Share
    • 3.2.4. Economies of Scale
    • 3.2.5. Hospital vs. Central Lab
    • 3.2.6. Physician Office Lab's
    • 3.2.7. Physician's and POCT
  • 3.3. Immunoassay -Markets and Discussion
    • 3.3.1. Instruments-Genetics changes the picture
      • 3.3.1.1. RIA-A Technology Shows its Age
      • 3.3.1.2. Immunoassay vs. PCR vs. Sequencing-A See Saw Battle
      • 3.3.1.3. The Smart Shrinking Instrument-Serious Implications
      • 3.3.1.4. Research Funding and Capital Expense-Instrument Pooling
      • 3.3.1.5. Multiplex vs. POC-A Tradeoff Analysis
    • 3.3.2. Reagents and Kits-Genetics changes the picture
      • 3.3.2.1. Bigger Test Menus a Boon for Kit Market
      • 3.3.2.2. Physician Office Labs-A New Frontier
    • 3.3.3. Rapid and POCT to Threaten Instrument Markets
    • 3.3.4. OTC and DTC-Huge Market Potential
    • 3.3.5. Economies of Scale. Going Away?
    • 3.3.6. Lower Barriers to Entry for Instruments/Analyzers
    • 3.3.7. Miniturization and Technology Drive Acquisition

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Diagnostic Factors
    • 4.1.2. Changing Technologies Spur Early Instrument Retirement
    • 4.1.3. Consumer Channels Open Wider
    • 4.1.4. Immunity Technology Comes of Age
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Threat from PCR Based Instruments
    • 4.2.3. Lower Barriers to Entry
    • 4.2.4. Wellness has a downside
  • 4.3. Immunoassay Instrumentation
    • 4.3.1. Instrumentation Tenacity
    • 4.3.2. Declining Cost of Instruments Changes Industry Structure
    • 4.3.3. Immunoassay-CRISPR Diagnostics

5. Immunoassay Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Single-Molecule Detection Tech Shows Promise
  • 5.3. QuidelOrtho Vitros Fentanyl Test
  • 5.4. Labcorp: Plasma Phosphorylated-Tau 217
  • 5.5. Renalytix Gets Immunoassay Medicare Coverage
  • 5.6. Roche to Acquire LumiraDx POC Tech
  • 5.7. Fujirebio, Sysmex to Collaborate on Immunoassay Development
  • 5.8. EDP Biotech, New Day Diagnostics to Merge
  • 5.9. Sorrento Therapeutics Nabs Contract for Dx Platform
  • 5.10. Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
  • 5.11. Qorvo Eyes Multiplex Immunoassay
  • 5.12. BioMerieux Launches New Products
  • 5.13. Senzo to Commercialize Infectious Disease Lateral Flow Tests
  • 5.14. Nanomix Plans Instrument, Test Launches
  • 5.15. Startup GLX Analytix Prepares for Commercialization
  • 5.16. Nonagen Gets CE Mark for Bladder Cancer Immunoassay
  • 5.17. Qualigen Acquires Majority Stake in NanoSynex
  • 5.18. Saladax Biomedical Using Immunoassay Dx
  • 5.19. Prolight Diagnostics to Acquire Psyros Diagnostics
  • 5.20. Quidel to Acquire Ortho Clinical Diagnostics

6. Profiles of Key Companies

  • 6.1. Abbott Laboratories
  • 6.2. Abcam
  • 6.3. Abionic
  • 6.4. Accel Diagnostics
  • 6.5. Agilent
  • 6.6. Akonni Biosystems
  • 6.7. Applied BioCode
  • 6.8. Arlington Scientific
  • 6.9. Arrayit Corporation
  • 6.10. Atomo Diagnostics
  • 6.11. Aureum Diagnostics
  • 6.12. Aurora Biomed
  • 6.13. Autobio Diagnostics
  • 6.14. AVIVA Systems Biology
  • 6.15. Awareness Technology
  • 6.16. Axis-Shield Diagnostics Ltd.
  • 6.17. Beckman Coulter Diagnostics (Danaher)
  • 6.18. Becton, Dickinson and Company
  • 6.19. Biocartis
  • 6.20. Biomatik
  • 6.21. bioMerieux Diagnostics
  • 6.22. Bioneer Corporation
  • 6.23. Bio-Rad Laboratories, Inc.
  • 6.24. Bio-Synthesis
  • 6.25. Bio-Techne
  • 6.26. Boditech Med, Inc
  • 6.27. Boster Biological Technology
  • 6.28. Bruker
  • 6.29. Cerstest Biotec
  • 6.30. Chembio
  • 6.31. CTK Biotech
  • 6.32. Cue Health
  • 6.33. Cytena
  • 6.34. Diasorin S.p.A.
  • 6.35. Dynex Technologies
  • 6.36. Eiken Chemical
  • 6.37. Enzo Biochem
  • 6.38. Eurofins Scientific
  • 6.39. Fluxion Biosciences (Cell Microsystems)
  • 6.40. FUJIFILM Wako Diagnostics
  • 6.41. Fujirebio
  • 6.42. Global Access Diagnostics
  • 6.43. Gold Standard Diagnostics
  • 6.44. Greiner Bio-One
  • 6.45. Grifols
  • 6.46. Hycor Biomedical
  • 6.47. Immunodiagnostic Systems (IDS)
  • 6.48. Iollo
  • 6.49. JR Biomedical
  • 6.50. LightDeck Diagnostics
  • 6.51. LumiraDx
  • 6.52. Maxim Biomedical
  • 6.53. Meso Scale Discovery
  • 6.54. Millipore Sigma
  • 6.55. Mindray
  • 6.56. Molecular Devices
  • 6.57. MP Biomedical
  • 6.58. Operon
  • 6.59. OraSure Technologies
  • 6.60. Qiagen
  • 6.61. QuidelOrtho
  • 6.62. R&D Systems
  • 6.63. Randox Toxicology
  • 6.64. R-Biopharm AG
  • 6.65. Response Biomedical
  • 6.66. Revvity
  • 6.67. Roche Diagnostics
  • 6.68. SD Biosensor
  • 6.69. Siemens Healthineers
  • 6.70. Standard BioTools
  • 6.71. Sysmex
  • 6.72. Tecan
  • 6.73. Thermo Fisher Scientific
  • 6.74. TOSOH Bioscience
  • 6.75. Uniogen
  • 6.76. Veramarx
  • 6.77. Veredus Laboratories
  • 6.78. Vircell
  • 6.79. Wantai Biopharm
  • 6.80. Werfen
  • 6.81. YD Diagnostics
  • 6.82. Zhejiang Orient Gene Biotech

7. The Global Market

  • 7.1. Global Market by Country
    • 7.1.1. Global Market by Country Table
    • 7.1.2. Global Market by Country Chart
  • 7.2. Global Market by Application
    • 7.2.1. Global Market by Application Table
    • 7.2.2. Global Market by Application Segment Growth Chart
    • 7.2.3. Global Market by Application Segment Annual Chart
    • 7.2.4. Global Market by Application Segment Base vs. Final
    • 7.2.5. Global Market by Application Base Year
    • 7.2.6. Global Market by Application Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Global Market by Technology Table
    • 7.3.2. Global Market by Technology Segment Growth Chart
    • 7.3.3. Global Market by Technology Segment Annual Chart
    • 7.3.4. Global Market by Technology Segment Base vs. Final
    • 7.3.5. Global Market by Technology Base Year
    • 7.3.6. Global Market by Technology Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Global Market by Product Table
    • 7.4.2. Global Market by Product Segment Growth Chart
    • 7.4.3. Global Market by Product Segment Annual Chart
    • 7.4.4. Global Market by Product Segment Base vs. Final
    • 7.4.5. Global Market by Product Base Year
    • 7.4.6. Global Market by Product Final Year
  • 7.5. Global Market by User
    • 7.5.1. Global Market by User Table
    • 7.5.2. Global Market by User Segment Growth Chart
    • 7.5.3. Global Market by User Segment Annual Chart
    • 7.5.4. Global Market by User Segment Base vs. Final
    • 7.5.5. Global Market by User Base Year
    • 7.5.6. Global Market by Application Final Year

8. Global Market by Application

  • 8.1. Endocrinology Applications
    • 8.1.1. Endocrinology Applications by Country Table
    • 8.1.2. Endocrinology Applications Growth Chart
  • 8.2. Immune Applications
    • 8.2.1. Immune Applications by Country Table
    • 8.2.2. Immune Applications Growth Chart
  • 8.3. Oncology Applications
    • 8.3.1. Oncology Applications by Country Table
    • 8.3.2. Oncology Applications Growth Chart
  • 8.4. Infectious Disease Applications
    • 8.4.1. Infectious Disease Applications by Country Table
    • 8.4.2. Infectious Disease Applications Growth Chart
  • 8.5. Cardiology Applications
    • 8.5.1. Cardiology Applications by Country Table
    • 8.5.2. Cardiology Applications Growth Chart
  • 8.6. Other Applications
    • 8.6.1. Other Applications by Country Table
    • 8.6.2. Other Applications Growth Chart

9. Immunoassay by Technology

  • 9.1. Enzyme
    • 9.1.1. Enzyme by Country Table
    • 9.1.2. Enzyme Growth Chart
  • 9.2. Flourescence
    • 9.2.1. Flourescence by Country Table
    • 9.2.2. Flourescence Growth Chart
  • 9.3. Chemiluminescence
    • 9.3.1. Chemiluminescence by Country Table
    • 9.3.2. Chemiluminescence Growth Chart
  • 9.4. Nucleic Acid
    • 9.4.1. Nucleic Acid by Country Table
    • 9.4.2. Nucleic Acid Growth Chart
  • 9.5. Rapid/POC
    • 9.5.1. Rapid/POC by Country Table
    • 9.5.2. Rapid/POC Growth Chart
  • 9.6. Other Technology
    • 9.6.1. Other Technology by Country Table
    • 9.6.2. Other Technology Growth Chart

10. Immunoassay by Product

  • 10.1. Instrument
    • 10.1.1. Instrument by Country Table
    • 10.1.2. Instrument Growth Chart
  • 10.2. Reagents
    • 10.2.1. Reagents by Country Table
    • 10.2.2. Reagents Growth Chart
  • 10.3. Services
    • 10.3.1. Services by Country Table
    • 10.3.2. Services Growth Chart

11. Immunoassay by User

  • 11.1. Hospital
    • 11.1.1. Hospital by Country Table
    • 11.1.2. Hospital Growth Chart
  • 11.2. Outpatient Lab
    • 11.2.1. Outpatient Lab by Country Table
    • 11.2.2. Outpatient Lab Growth Chart
  • 11.3. POC/Other
    • 11.3.1. POC/Other by Country Table
    • 11.3.2. POC/Other Growth Chart

12. Vision of the Future of Immunoassay

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus-Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: The Different Markets for Immunoassay
  • Table 6: The Factors Driving Growth
  • Table 7: Factors Limiting Growth
  • Table 8: The Global Immunoassay Market by Country
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Product
  • Table 12: Global Market by User
  • Table 13: Endocrinology Immunoassay by Country
  • Table 14: Immune Immunoassay by Country
  • Table 15: Oncology Immunoassay by Country
  • Table 16: Infectious Disease Immunoassay by Country
  • Table 17: Cardiology Immunoassay by Country
  • Table 18: Other Immunoassay by Country
  • Table 19: Enzyme Immunoassay by Country
  • Table 20: Flourescence Immunoassay by Country
  • Table 21: Chemiluminescence Immunoassay by Country
  • Table 22: Nucleic Acid Immunoassay by Country
  • Table 23: Rapid/POC Immunoassay by Country
  • Table 24: Other Technology Immunoassay by Country
  • Table 25: Instrument by Country
  • Table 26: Reagents by Country
  • Table 27: Services by Country
  • Table 28: Hospital Usrr by Country
  • Table 29: Outpatient Lab by Country
  • Table 30: POC/Other by Country
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays
  • Table 33: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: The Road to Diagnostics
  • Figure 4: Immunoassay-Country Sharea
  • Figure 5: Chart of Growth by Application
  • Figure 6: Chart of Segment by Year
  • Figure 7: Chart of Base vs. Final
  • Figure 8: Chart of Base Year by Application
  • Figure 9: Chart of Final Year by Application
  • Figure 10: Chart of Growth by Technology
  • Figure 11: Chart of Technology Segment by Year
  • Figure 12: Chart of Technology Base vs. Final
  • Figure 13: Chart of Base Year by Technology
  • Figure 14: Chart of Final Year by Technology
  • Figure 15: Chart of Growth by Product
  • Figure 16: Chart of Product Segment by Year
  • Figure 17: Chart of Product Base vs. Final
  • Figure 18: Chart of Base Year by Product
  • Figure 19: Chart of Final Year by Product
  • Figure 20: Chart of Growth by User
  • Figure 21: Chart of User Segment by Year
  • Figure 22: Chart of User Base vs. Final
  • Figure 23: Chart of Base Year by User
  • Figure 24: Chart of Final Year by User
  • Figure 25: Chart-Endocrine Segment vs Total Market Growth
  • Figure 26: Chart-Immune Growth vs. Total
  • Figure 27: Chart-Oncology vs Total
  • Figure 28: Chart-Infectious Disease Immunoassay vs Total
  • Figure 29: Chart-Cardiology Immunoassay vs total
  • Figure 30: Chart-Other Immunoassay vs Total
  • Figure 31: Chart-Enzyme Segment vs Total Market Growth
  • Figure 32: Chart-Flourescence Growth vs. Total
  • Figure 33: Chart-Chemiluminescence vs Total
  • Figure 34: Chart-Nucleic Acid Immunoassay vs Total
  • Figure 35: Chart-Rapid/POC Immunoassay vs total
  • Figure 36: Chart-Other Technology Immunoassay vs Total
  • Figure 37: Chart-Instrument Segment vs Total Market Growth
  • Figure 38: Chart-Reagents Growth vs. Total
  • Figure 39: Chart-Services vs Total
  • Figure 40: Chart-Hospital Segment vs Total Market Growth
  • Figure 41: Chart-Outpatient Lab Growth vs. Total
  • Figure 42: Chart-POC/Other vs Total
  • Figure 43: IVD Test Menu Growth
  • Figure 44: IVD Test Average Fees-A Ten Year View